According to Shanghai RAAS Blood Products's latest financial reports the company's current revenue (TTM ) is โน98.55 Billion. In 2024 the company made a revenue of โน97.45 Billion an increase over the revenue in the year 2023 that were of โน93.66 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.